FR2338044A1 - Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubility - Google Patents
Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubilityInfo
- Publication number
- FR2338044A1 FR2338044A1 FR7600793A FR7600793A FR2338044A1 FR 2338044 A1 FR2338044 A1 FR 2338044A1 FR 7600793 A FR7600793 A FR 7600793A FR 7600793 A FR7600793 A FR 7600793A FR 2338044 A1 FR2338044 A1 FR 2338044A1
- Authority
- FR
- France
- Prior art keywords
- alpha
- ethaverine
- hydrochlorides
- glycerophosphate
- degrees
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/18—Aralkyl radicals
- C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The alpha- and beta-glycerophosphates of papaverine and ethaverine are new. They have greater solubility then the free bases or hydrochlorides (>50% for the papering derivs. and 7% and 2.5% for the alpha- and beta-ethaverine derivs. esp.) They have reduced toxicity and the same musculotropic spasmolytic activity as the hydrochlorides. LD50 for ethererine alpha-glycerophosphate (i.v.) is 70 mg/kg compared with 51 for the hydrochloride. typical tables contain 100 mg ethererine beta-glycerophosphate. Dose is 1-4 tablets/day. In an example, an aq. soln. of alpha-glycerophosphoric acid (obtd. by treating disodium alpha-glycerophosphate with a strongly acid cationic resin) contg. 1/10 mole of acid in 1 l H2O was heated to 50 degrees C. It was mixed with a soln. of 1/10 mole papering in 400 ml ethanol, also at 50 degrees C. Prod. was filtered and conc. in vacuo at 50 degrees C. Recrystallisation from 400 ml hot 95% ethanol have papering alpha-glycerophosphate, m.pt. 110-120 degrees C.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7600793A FR2338044A1 (en) | 1976-01-14 | 1976-01-14 | Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubility |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7600793A FR2338044A1 (en) | 1976-01-14 | 1976-01-14 | Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubility |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2338044A1 true FR2338044A1 (en) | 1977-08-12 |
FR2338044B1 FR2338044B1 (en) | 1980-04-30 |
Family
ID=9167892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7600793A Granted FR2338044A1 (en) | 1976-01-14 | 1976-01-14 | Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubility |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2338044A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017971A1 (en) * | 2002-08-08 | 2004-03-04 | Ursapharm Arzneimittel Gmbh & Co. Kg | Use of a papaverine-like vasodilator and pharmaceutical composition |
-
1976
- 1976-01-14 FR FR7600793A patent/FR2338044A1/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004017971A1 (en) * | 2002-08-08 | 2004-03-04 | Ursapharm Arzneimittel Gmbh & Co. Kg | Use of a papaverine-like vasodilator and pharmaceutical composition |
Also Published As
Publication number | Publication date |
---|---|
FR2338044B1 (en) | 1980-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE49198T1 (en) | ANTI-INFLAMMATORY 1,N-DIARYLPYRAZOLE-3-AMINES, THEIR COMPOSITIONS AND PROCESS FOR THEIR PRODUCTION. | |
IE801806L (en) | ß-CARBOLIN-3-CARBOXYLIC ACID DERIVATIVES | |
NZ501276A (en) | 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors in treating proliferative disorders | |
MY108261A (en) | Water soluble camptothecin derivatives | |
MX9704745A (en) | Piperazine derivatives, medicaments containing the same, their use and process for preparing the same. | |
UA26403A (en) | POHIDHI N-ZAMISCHEHOHO 4 FEHIL-4-PIPERYDYHKARBOKSAMIDU FARMATSEVTYCHHO PRYYHYATHI AND THEIR SALTS, showing AHESTEZUVALHU AHALHEZUVALHU AND PERFORMANCE, AND METHOD OF ODERZHAHHYA FARMATSEVTYCHHA COMPOSITION | |
SE9300758L (en) | Process for Preparation of Cavulanic Acid Salts | |
FR2338044A1 (en) | Glycero-phosphates of papaverine and ethaverine - have same musculotropic spasmolytic activity as free bases and hydrochlorides, but higher solubility | |
MY104829A (en) | 3-phenyl-5, 6-dihydrobenz [c]acridine-7-carboxylic acids and related compounds as cancer chemotherapeutic agents. | |
ES436340A1 (en) | Spasmolytics | |
ES476266A1 (en) | Cyclic diamine n,n'-disubstituted and process for preparing the same | |
ZA845931B (en) | 1-(4'-alkylsulphonylphenyl)-2-amino-1,3-propanediol n-substituted derivatives | |
IE41509L (en) | Process for di- and triamino naphthalene production | |
ES405479A1 (en) | Benzodiazepin-2-ones | |
GB1351505A (en) | Terpene derivatives method for their preparation and applications thereof | |
GB1457005A (en) | 2-substituted-3-aminoquinoxalines | |
GB1325280A (en) | 3-substituted-as-triazino-5,6-c-quinolines | |
IE39800L (en) | 4-amino-3-hydrazino-1,2,4-triazole derivatives | |
JPS5651460A (en) | Pyrimidine derivative, its preparation, and antitumor agent comprising its derivative | |
GB1171827A (en) | Improvements in or relating to Substituted Propanols and the Manufacture thereof | |
GB1394409A (en) | Preparation of n-1-ethyl-2-pyrrolidylmethyl-2-methoxy-5- ethylsulphonyl-benzamide | |
ATE43586T1 (en) | ARPHAMEN INDIVIDUALS, PROCESSES FOR THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS. | |
GB1497827A (en) | Triazolobenzodiazepine derivatives | |
GB1168243A (en) | Basically Substituted 1,3-Dinitrobenzene Compounds and process for their manufacture | |
ES366841A1 (en) | Procedure for the preparation of benzodiacepine derivatives. (Machine-translation by Google Translate, not legally binding) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |